首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Postenucleation orbital radiotherapy for the treatment of malignant melanoma of the choroid with extrascleral extension.
【2h】

Postenucleation orbital radiotherapy for the treatment of malignant melanoma of the choroid with extrascleral extension.

机译:摘除核后眶放疗治疗巩膜外延伸的脉络膜恶性黑色素瘤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The outcome is reported in 17 patients in whom an eye was enucleated for malignant melanoma of the choroid with extrascleral extension and who subsequently underwent adjuvant external beam radiotherapy to the orbit as the primary treatment of the extraocular spread of their tumour. Extrascleral extension was encapsulated in five, non-encapsulated in two, and had been surgically transected at enucleation in 10 cases. All the patients have been followed up from enucleation to the present day. Orbital recurrence occurred in only one patient. The overall actuarial survival rate was 51% at 5 years, 44% at 10, and 33% at 15 years. A low orbital recurrence rate of 6% compares very favourably with published figures for this event after enucleation for melanoma with extrascleral extension but without radiotherapy. Adjuvant orbital radiotherapy may have a place in the treatment of selected cases of extracleral extension of intraocular malignant melanoma.
机译:据报道有17例患者的结局,其中因巩膜外延伸的脉络膜恶性黑色素瘤摘除了眼球,随后接受了眼眶辅助放射束外照射,作为其肿瘤眼外扩散的主要治疗方法。巩膜外延伸物被封装在五个中,非封装物被封装在两个中,并且在去核时已通过手术切除了10例。从摘除手术到今天,对所有患者进行了随访。仅一名患者发生眼眶复发。总体精算生存率在5年时为51%,在10年时为44%,在15年时为33%。眼球复发率低至6%,与已公布的巩膜外延张但未放疗的黑色素瘤摘除后的事件数字非常吻合。眼眶恶性黑色素瘤的巩膜外延伸的某些病例可能需要行辅助轨道放疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号